HIT Consultant

AUGUST 5, 2022

What You Should Know: – The index of Healthcare & Life Science equities tracked by Stout was down 16.8% – Healthcare & Life Science M&A activity plummeted to 338 deals in Q2 2022 versus 535 in Q2 2021 and a record 565 deals in Q4 2021. Medical Device equities were down 18.5%

Life Sciences 98

Life Sciences Telemedicine Healthcare Biotechnology 98

HIT Consultant

APRIL 5, 2023

What You Should Know: Dot Compliance , a leading provider of eQMS compliance solutions for the life sciences sector, has introduced an industry-first, ready-to-use AI-Based electronic Quality Management System for life sciences, powered by an embedded generative and predictive artificial intelligence.

Life Sciences 98

Life Sciences Quality Assurance Pharmaceuticals Regulations 98

HIT Consultant

MARCH 26, 2023

While the pharmaceutical industry and life sciences are often criticized for slow technological adoption, the metaverse presents an enormous opportunity for early adoption built on a clear understanding of value. He has 25 years of tech experience, including 16 years in the life sciences industry.

Life Sciences 98

Life Sciences Pharmaceuticals Regulations Hospitals 98

HIT Consultant

SEPTEMBER 16, 2022

What You Should Know: – Epic launches Life Sciences program, expanding its work to bring together the disconnected parts of healthcare. The initial focus of the Life Sciences program includes: – Matching participating providers with clinical trial opportunities suited to the makeup of their patient populations.

Life Sciences 96

Life Sciences Pharmaceuticals Healthcare 96

HIT Consultant

OCTOBER 10, 2024

In a time when healthcare is always changing, the pharmaceutical sector is under more pressure to ensure patient safety while maintaining compliance with stringent regulatory standards. As the complexity of pharmaceutical delivery rises, technology has become ever more crucial in tracking and safeguarding pharmacological products.

Pharmaceuticals 110

Pharmaceuticals Patient Safety Regulations Healthcare Providers 110

HIT Consultant

NOVEMBER 6, 2023

What You Should Know: – Accenture and Salesforce are investing in the development of Salesforce Life Sciences Cloud, focusing on innovation, assets, and accelerators powered by data and artificial intelligence (AI) to help life sciences companies create sustainable value and drive growth.

Life Sciences 52

Life Sciences Pharmaceuticals Patient Experience Healthcare 52

HIT Consultant

MAY 2, 2022

Although it is well established that diversity improves outcomes and drives excellence, implementing diversity lags behind in many industries, including life sciences and healthcare. The pharmaceutical industry differs in many ways from other industries. Other Steps Life Sciences Companies Can Take to Improve Diversity.

Life Sciences 98

Life Sciences Pharmaceuticals Healthcare Providers Healthcare 98

HIT Consultant

JUNE 13, 2023

What You Should Know: Nearly three-fourths of life sciences organizations surveyed have invested in digital pathology to advance drug research and development (R&D), according to new research commissioned by Proscia®. Pharmaceutical leaders should consider fully incorporating this data into their workflows.

Life Sciences 52

Life Sciences Pharmaceuticals 52

HIT Consultant

JULY 18, 2022

Dan UpDyke, Strategic Marketing Manager Life Sciences at Rockwell Automation. The ability to navigate constant disruption is a prerequisite for success in today’s life science industries. Mounting Challenges for Life Sciences Companies. million skilled jobs by 2030. .

Life Sciences 89

Life Sciences Pharmaceuticals Integration Regulations 89

HIT Consultant

NOVEMBER 9, 2022

Salesforce Solutions for Healthcare & Life Sciences. Wilco Source provides enterprise solutions for many leading healthcare and life sciences organizations and has developed multiple accelerators and solutions, including: – Digital front door (i.e., patient and provider portals) (Salesforce Communities).

Life Sciences 52

Life Sciences Pharmaceuticals Healthcare Integration 52

Bill Of Health

FEBRUARY 18, 2022

The changing landscape of the life sciences industry relies more and more on a form of intellectual property protection called trade secrets to safeguard mechanisms of manufacturing and process knowledge not always included within life science patents. By Matt Bauer.

Life Sciences 83

Life Sciences Pharmaceuticals Biotechnology 83

HIT Consultant

AUGUST 20, 2024

In the rapidly evolving world of pharmaceuticals, artificial intelligence (AI) is emerging as a game-changer. This predictive capability can help pharmaceutical companies make informed decisions about whether to proceed with a trial, adjust the trial design, or even abandon a trial that is unlikely to succeed.

Pharmaceuticals 111

Pharmaceuticals Integration Accountability Life Sciences 111

Lexis Nexis

MAY 17, 2023

The Healthcare Businesswomen’s Association (HBA) recognized Liz Paulson, LexisNexis® Risk Solutions Life Science Leader, with its prestigious STAR Award at its Woman of the Year luncheon on May 16, 2023. I decided to pursue work in pharmaceuticals next so I could help more than one individual at a time and have a greater impact.

Life Sciences 52

Life Sciences Pharmaceuticals Healthcare Accountability 52

Healthcare ECONOMIST

MAY 10, 2023

Today I’m turning this post over to some of my FTI colleagues in Europe ( Antoine Mialhe , Katja Murray and Valeria Fagone among others) who helped summarize the Reform of the EU pharmaceutical legislation that the European Union (EU) adopted on April 26, 2023. A more detailed analysis is in the PDF link below.

Pharmaceuticals 74

Pharmaceuticals Regulations Life Sciences Hospitals 74

Healthcare ECONOMIST

JANUARY 18, 2023

That is the takeaway according to a November-December 2022 survey by PhRMA of 25 large pharmaceutical manufacturers. Among respondents, it was clear the IRA price setting provisions are already impacting, and are expected to have a growing impact on, R&D plans moving forward: • 78% expect to cancel early-state pipeline projects. •

Life Sciences 79

Life Sciences Pharmaceuticals 79

HIT Consultant

FEBRUARY 13, 2023

Two major pharmaceutical companies are currently beta testing it, putting them at the forefront of leveraging AI enterprise-wide to advance new medicines for patients most in need. It’s not simply the proprietary AI that’s revolutionary.

Pharmaceuticals 98

Pharmaceuticals Life Sciences 98

HIT Consultant

JUNE 26, 2024

In 2022, the FDA released draft guidance outlining strategies for pharmaceutical companies to improve participation from underrepresented racial and ethnic groups in clinical trials. As the FDA finalizes these guidelines, pharmaceutical companies are expected to continue prioritizing investments in diversity initiatives.

Life Sciences 90

Life Sciences Pharmaceuticals Quality of Care Regulations 90

Healthcare It News

JANUARY 31, 2024

They can quickly be integrated into manufacturing lines, which means embedded RFID technologies are no longer hindering pharmaceutical manufacturing. “Manufacturers only have to use one encoding scheme for all healthcare and life sciences customers, which should help with adoption moving forward.

Healthcare 298

Healthcare Pharmaceuticals Patient Safety Life Sciences 298

HIT Consultant

DECEMBER 7, 2023

Leading Pharmaceutical Advances Globally Yseop, a pioneer in Generative AI for medical and regulatory writing, has automated critical aspects of the clinical document landscape, such as Clinical Study Reports and Patient Narratives.

Life Sciences 98

Life Sciences Pharmaceuticals Integration 98

HIT Consultant

DECEMBER 11, 2023

What You Should Know: – Medtronic announced an expanded AI partnership with Cosmo Pharmaceuticals NV , a pharmaceutical company, to further advance AI-powered solutions in the medical field. Cosmo Pharmaceuticals remains the exclusive manufacturer of the platform.

Pharmaceuticals 52

Pharmaceuticals Integration Healthcare Life Sciences 52

HIT Consultant

OCTOBER 25, 2022

The proportion of pharmaceutical companies hiring for AI-related positions kept relatively steady in May 2022 compared with the equivalent month last year, according to a Pharmaceutical Technology study, with 39.3% of the companies included in the analysis recruiting for at least one such position. . Operational Challenges of AI.

Pharmaceuticals 98

Pharmaceuticals Regulations Doctors Health Technology 98

HIT Consultant

SEPTEMBER 19, 2023

The funding will support Briya’s mission to transform how data is exchanged between healthcare organizations and life sciences organizations, with particular emphasis on supporting the United States health ecosystem. The company’s scalable data exchange platform enables hospitals to capitalize on their patient data. .”

Life Sciences 124

Life Sciences Healthcare Pharmaceuticals Hospitals 124

HIT Consultant

NOVEMBER 1, 2024

This groundbreaking initiative seeks to advance the discovery and development of novel small molecules for drug development, sustainable crop protection, and other innovative products across a wide range of life-science industries. What You Should Know: – Evogene Ltd.

Life Sciences 52

Life Sciences Pharmaceuticals Integration 52

HIT Consultant

OCTOBER 31, 2024

Rather, pharmacy encompasses a myriad of angles in health care – the pharmaceutical commercialization process, benefits coverage and therapy tiering, drug cost management, distribution regulations – the list could go on and on. This is where drugs come to patients and where patients see life-changing benefits of medications.

Life Sciences 98

Life Sciences Pharmaceuticals Regulations Integration 98

HIT Consultant

DECEMBER 7, 2023

With oncology drug sales set to top $390 billion by 2027 , life science companies are aligning efforts to prioritize this critical market opportunity ahead of competitors. In this nuanced landscape, pharmaceutical companies play a vital role in driving advancements in cancer care.

Life Sciences 98

Life Sciences Pharmaceuticals Accountability Healthcare Improvement 98

HIT Consultant

MAY 1, 2023

What You Should Know: ODAIA , developers of MAPTUAL, an AI-powered commercial insights SaaS platform for pharmaceutical companies, announced it raised an oversubscribed $25 Million Series B financing round, led by Threshold Ventures and co-led by Monograph Capital. We’re thrilled to lead their Series B financing.

Life Sciences 96

Life Sciences Pharmaceuticals Healthcare Providers Healthcare 96

HIT Consultant

OCTOBER 2, 2024

– These powerful new tools empower life sciences organizations to leverage the full potential of artificial intelligence in pathology, leading to faster breakthroughs and improved patient outcomes.

Life Sciences 105

Life Sciences Pharmaceuticals Integration 105

HIT Consultant

MARCH 21, 2024

Director of Business Development at IQVIA The healthcare industry is no stranger to workforce shortages, and the pharmaceutical industry may be next to experience disruptions brought on by labor challenges. Bureau of Labor Statistics, it is estimated that occupations across life, physical and social sciences are expected to grow 7% by 2028.

Life Sciences 97

Life Sciences Pharmaceuticals Patient Safety Regulations 97

HIT Consultant

JUNE 6, 2023

Simon Johns, Director of Medical Information and Marketed Product Safety at IQVIA Pharmaceutical companies across the globe are currently investing in artificial intelligence (AI) to overcome challenges surrounding the support of inquiries from healthcare professionals (HCPs). Why Use AI-enabled Agents for Medical Information (MI) Operations?

Life Sciences 98

Life Sciences Pharmaceuticals Integration Healthcare 98

Healthcare It News

OCTOBER 7, 2021

Matching patients to clinical trials they are eligible for has been a major challenge for everyone from pharmaceutical companies to hospitals. We also worked with a large pharmaceutical company to validate the problem area and solution design." THE PROBLEM. " Sean T. Manion, ConsenSys Health. " RESULTS.

Life Sciences 282

Life Sciences Pharmaceuticals Regulations Health Data 282

HIT Consultant

APRIL 11, 2023

– As CCO, Sandy will drive COTA’s life sciences growth strategy, prioritizing customer success and experience. – Sandy Leonard is a digital health leader with more than 20 years of deep pharmaceutical and real-world data expertise, will lead COTA’s business expansion efforts during a period of strong, sustainable growth.

Life Sciences 97

Life Sciences Pharmaceuticals 97

HIT Consultant

OCTOBER 22, 2024

Christopher Wooden, Senior Director, Business Marketing, IQVIA A critical aspect of any pharma/life sciences commercialization strategy is to develop and deploy effective and meaningful ways to engage, inform and build trust with healthcare providers (HCPs). Figure 3.

Life Sciences 97

Life Sciences Healthcare Pharmaceuticals Clinical Practice 97

HIT Consultant

SEPTEMBER 26, 2022

Subhro Mallik, SVP & Head of Life Sciences at Infosys. The new normal has thrown up opportunities as well as risks for pharmaceutical companies. The application of digital technologies in pharmaceuticals – digiceuticals – is a promising way forward. There was tremendous interest in telemedicine before 2020.

Life Sciences 97

Life Sciences Pharmaceuticals Telemedicine Healthcare Providers 97

HIT Consultant

APRIL 7, 2022

Now, it is expanding into life sciences to broaden the continuum of care with a groundbreaking AI-driven life science platform, a first-of-its-kind solution that revolutionizes the way medical device and pharmaceutical companies perform clinical trials and bring their treatments to market.

Life Sciences 98

Life Sciences Pharmaceuticals Hospitals 98

HIT Consultant

JULY 10, 2024

. – These AI enhancements cater to the evolving needs of life science organizations, allowing them to navigate increasingly complex regulatory landscapes and manage rising adverse event caseloads.

Life Sciences 97

Life Sciences Pharmaceuticals Regulations 97

HIT Consultant

MAY 21, 2024

What You Should Know: – Sanofi , a global pharmaceutical leader, Formation Bio , an AI-powered drug developer, and OpenAI , a leading research and development company in artificial intelligence, have announced a groundbreaking collaboration.

Life Sciences 72

Life Sciences Pharmaceuticals 72

HIT Consultant

NOVEMBER 13, 2024

This collaboration also introduces a transformative approach to patient marketing, particularly for pharmaceutical companies. By targeting the “invisible patient”—those undiagnosed individuals navigating complex health issues—this partnership allows companies to engage with a previously difficult-to-reach patient population.

Pharmaceuticals 98

Pharmaceuticals Life Sciences Integration Healthcare Innovation 98